首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Nitric oxide synthase activity and renal injury in genetic hypertension.
【24h】

Nitric oxide synthase activity and renal injury in genetic hypertension.

机译:一氧化氮合酶活性与遗传性高血压肾损害

获取原文
获取原文并翻译 | 示例
           

摘要

Nitric oxide (NO) is an endogenous vasodilator synthesized in the endothelium by constitutive NO synthase (cNOS). We have shown that upregulation of cNOS activity in hypertension may contribute to forestalling left ventricular and aortic hypertrophy (Hypertension. 29: 235, 1997). NO has been shown to inhibit growth-related responses affecting vascular smooth muscle, and mesangial cells, as well as reduce production of extracellular matrix in response to injury. Here, we investigated the relationship between renal cNOS activity (conversion of [14C] L-arginine to [14C] L-citrulline) and glomerular (GIS) and tubulointerstitial (TIS) injury scores and urinary protein excretion, indices of renal injury, in age and blood pressure matched spontaneously hypertensive rats (SHR, SBP 220+/-9 mm Hg) fed 0.5% NaCl diet and Dahl salt-sensitive (DS) rats fed 4% NaCl diet (DS-4%, SBP 228+/-8 mm Hg) as well as their normotensive counterparts Wistar Kyoto rats fed 0.5% NaCl diet (WKY, 137+/-3 mm Hg) and DS rats fed 0.5% NaCl diet (DS-0.5%, SBP 135+/-4 mm Hg). In SHR, renal medullary cNOS activity was 89% higher than in WKY (8.91+/-0.98 vs 4.71+/-0.37 nmol/min/g protein, P<0.05) whereas, in hypertensive DS-4% rats cNOS activity was 43% lower than in DS-0.5% rats (1.98+/-0.16 vs 3.48+/-0.29 nmol/min/g protein, P<0.05). Renal cortical cNOS was lower than in medulla but similar in all groups; inducible NOS activity was not detected. Despite hypertension of similar severity and duration, hypertensive DS-4% developed 9 fold more GIS (190+/-42 vs 21+/-11), 20 fold more TIS (4.0+/-0.7 vs 0.2+/-0.3), and 5 fold more proteinuria (54+/-11 vs 8.5+/-3.0 mg/day), all P<0.05. The current studies, in conjunction with our recent studies in heart and aorta, strongly suggest that in hypertension, increased cNOS activity may provide a protective homeostatic role in all the end-organs that are targets of hypertensive injury.
机译:一氧化氮(NO)是内在的血管扩张剂,由一氧化氮合酶(cNOS)在内皮中合成。我们已经表明,高血压中cNOS活性的上调可能有助于阻止左心室和主动脉肥大(Hypertension。29:235,1997)。已经显示,NO可以抑制与生长有关的反应,从而影响血管平滑肌和肾小球膜细胞,并减少因损伤而引起的细胞外基质的产生。在这里,我们调查了肾脏cNOS活性([14C] L-精氨酸向[14C] L-瓜氨酸的转化)与肾小球(GIS)和肾小管间质(TIS)损伤评分和尿蛋白排泄,肾损伤指数之间的关系。年龄和血压相匹配的自发性高血压大鼠(SHR,SBP 220 +/- 9 mm Hg)喂养0.5%NaCl日粮和Dahl盐敏感性(DS)大鼠喂养4%NaCl日粮(DS-4%,SBP 228 +/- 8 mm Hg)及其血压正常的Wistar Kyoto大鼠饲喂0.5%NaCl饮食(WKY,137 +/- 3 mm Hg)和DS大鼠饲喂0.5%NaCl饮食(DS-0.5%,SBP 135 +/- 4 mm汞)。在SHR中,肾髓质cNOS活性比WKY高89%(8.91 +/- 0.98对4.71 +/- 0.37 nmol / min / g蛋白,P <0.05),而在高血压DS-4%大鼠中,cNOS活性为43与DS-0.5%大鼠相比降低了%(1.98 +/- 0.16 vs 3.48 +/- 0.29 nmol / min / g蛋白质,P <0.05)。肾皮质cNOS低于髓质,但在所有组中相似;未检测到诱导型NOS活性。尽管高血压的严重程度和持续时间相似,但高血压DS-4%的GIS增长了9倍(190 +/- 42对21 +/- 11),TIS增长了20倍(4.0 +/- 0.7对0.2 +/- 0.3),和5倍以上的蛋白尿(54 +/- 11对8.5 +/- 3.0 mg /天),所有P <0.05。当前的研究与我们最近在心脏和主动脉中的研究相结合,有力地表明,在高血压中,增加的cNOS活性可能在所有作为高血压损伤靶标的终末器官中起到保护稳态作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号